- Home
- ALZN vs ISPC Comparison
ALZN vs ISPC Comparison
Compare ALZN & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- ISPC
- Stock Information
- Founded
- ALZN 2016
- ISPC 2009
- Country
- ALZN United States
- ISPC United States
- Employees
- ALZN N/A
- ISPC N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- ISPC Precision Instruments
- Sector
- ALZN Health Care
- ISPC Health Care
- Exchange
- ALZN Nasdaq
- ISPC Nasdaq
- Market Cap
- ALZN 7.5M
- ISPC 6.9M
- IPO Year
- ALZN 2021
- ISPC 2021
- Fundamental
- Price
- ALZN $2.35
- ISPC $0.84
- Analyst Decision
- ALZN Strong Buy
- ISPC
- Analyst Count
- ALZN 1
- ISPC 0
- Target Price
- ALZN $42.00
- ISPC N/A
- AVG Volume (30 Days)
- ALZN 132.3K
- ISPC 594.2K
- Earning Date
- ALZN 12-11-2025
- ISPC 11-14-2025
- Dividend Yield
- ALZN N/A
- ISPC N/A
- EPS Growth
- ALZN N/A
- ISPC N/A
- EPS
- ALZN N/A
- ISPC N/A
- Revenue
- ALZN N/A
- ISPC $5,908,088.00
- Revenue This Year
- ALZN N/A
- ISPC $35.93
- Revenue Next Year
- ALZN N/A
- ISPC N/A
- P/E Ratio
- ALZN N/A
- ISPC N/A
- Revenue Growth
- ALZN N/A
- ISPC N/A
- 52 Week Low
- ALZN $2.06
- ISPC $0.64
- 52 Week High
- ALZN $15.21
- ISPC $5.48
- Technical
- Relative Strength Index (RSI)
- ALZN 48.08
- ISPC 43.67
- Support Level
- ALZN $2.27
- ISPC $0.80
- Resistance Level
- ALZN $2.56
- ISPC $0.86
- Average True Range (ATR)
- ALZN 0.16
- ISPC 0.07
- MACD
- ALZN 0.01
- ISPC 0.01
- Stochastic Oscillator
- ALZN 50.71
- ISPC 54.36
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.